AWM
AXSM icon

Ameliora Wealth Management’s Axsome Therapeutics AXSM Stock Holding History

Ameliora Wealth Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-500
Closed -$38.6K – 219
2022
Q4 		$38.6K Hold
500
– – 0.02% 159
2022
Q3 		$20K Buy
+500
New +$25K 0.01% 176

Other funds holding AXSM

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Ameliora Wealth Management's AXSM Position: Q1 2023 in Review

Ameliora Wealth Management sold out of Axsome Therapeutics (AXSM) in Q1 2023, closing a stake of 500 shares — an estimated $38.6K sold.

Ameliora Wealth Management first reported a position in AXSM in Q3 2022 and held it in 2 quarters. The position peaked at $38.6K in Q4 2022. 196 funds tracked by Wall St. Rank hold AXSM as of Q1 2023.

  • Ameliora Wealth Management reported no remaining Axsome Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Ameliora Wealth Management sold 500 Axsome Therapeutics shares in Q1 2023, an estimated $38.6K.
  • Ameliora Wealth Management first reported a position in Axsome Therapeutics in Q3 2022 and held it in 2 quarters.
  • Ameliora Wealth Management's Axsome Therapeutics position peaked at $38.6K in Q4 2022.
  • 196 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2023.

Based on Ameliora Wealth Management's 13F filing for Q1 2023, filed 17 Apr 2023.